Acute effects of D1- and D2-receptor agonist and antagonist drugs on somatostatin binding, inhibition of adenylyl cyclase activity and accumulation of inositol 1,4,5-trisphosphate in the rat striatum

Molecular Brain Research

Volumn 47, Issue 1-2, 1997, Pages 99-107

  Izquierdo Claros, Rosa María ^a   Del Carmen Boyano Adánez, María ^a   Larsson, Christer ^b   Gustavsson, Lena ^b   Arilla, Eduardo ^a  

^a UNIVERSITY OF ALCALÁ   (Spain)

^b LUND UNIVERSITY   (Sweden)

Author keywords

Adenylyl cyclase; Bromocriptine; Inositol 1,4,5 trisphosphate; Raclopride; SCH 23390; SKF 38393; Somatostatin receptor; Striatum

Indexed keywords

2,3,4,5 TETRAHYDRO 7,8 DIHYDROXY 1 PHENYL 1H 3 BENZAZEPINE; 8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; ADENYLATE CYCLASE; BROMOCRIPTINE; DOPAMINE 1 RECEPTOR; DOPAMINE 2 RECEPTOR; FORSKOLIN; INOSITOL 1,4,5 TRISPHOSPHATE; OCTREOTIDE; RACLOPRIDE; SOMATOSTATIN; DOPAMINE RECEPTOR BLOCKING AGENT; DOPAMINE RECEPTOR STIMULATING AGENT; SOMATOSTATIN RECEPTOR;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINERGIC SYSTEM; ENZYME INHIBITION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; ANIMAL; DOSE RESPONSE; DRUG EFFECT; METABOLISM; TIME; WISTAR RAT;

ADENYLATE CYCLASE; ANIMALS; CORPUS STRIATUM; DOPAMINE AGONISTS; DOPAMINE ANTAGONISTS; DOSE-RESPONSE RELATIONSHIP, DRUG; INOSITOL 1,4,5-TRISPHOSPHATE; MALE; RATS; RATS, WISTAR; RECEPTORS, DOPAMINE D1; RECEPTORS, DOPAMINE D2; RECEPTORS, SOMATOSTATIN; TIME FACTORS;

EID: 0343118774     PISSN: 0169328X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-328X(97)00063-6     Document Type: Article

References (67)

1. 2+ mobilization by cloned human somatostatin receptor subtypes 1-5, in transfected COS-7 cells, FEBS Lett., 348 (1994) 192-196.
2. Antoniotti, H., Fagot-Revurat, P., Fourmy, E.D., Pradayrol, L. and Ribet, A., Purification of radioiodinated somatostatin-related peptides by reversed-phase high-performance liquid chromatography, J. Chromatogr., 296 (1984) 181-188.
3. 2 receptor antagonists decrease prosomatostatin mRNA expression in rat striatum, Neuroscience, 44 (1991) 35-44.
4. 2 Dopamine receptor-mediated inhibition of forskolin-stimulated adenylate cyclase activity in rat striatum, Neurosci. Lett., 59 (1985) 177-182.
5. Beal, M.F. and Martin, J.B., The effect of somatostatin on striatal catecholamines, Neurosci. Lett., 44 (1983) 271-276.
6. Beal, M.F. and Martin, J.B., Effects of neuroleptic drugs on brain somatostatin-like inmunoreactivity, Neurosci. Lett., 47 (1984) 125-130.
7. Berelowitz, M., Maeda, K., Harris, S. and Frohman, L.A., The effect of alterations in the pituitary-thyroid axis on hypothalamic content and in vitro release of somatostatin-like immunoreactivity, Endocrinology, 107 (1980) 24-29.
8. Berridge, M.J., Inositol trisphosphate and calcium signalling, Nature, 361 (1993) 315-325.
9. 2 subtypes of dopamine receptors in rat brain, J. Neurosci., 6 (1986) 3177-3188.
10. Bredt, D.S., Mourey, R.J. and Snyder, S.H., A simple, sensitive, and specific radioreceptor assay for inositol-1,4,5-trisphosphate in biological tissues, Biochem. Biophys. Res. Commun., 3 (1989) 976-982.
11. Brunns, C., Weckbecker, G., Raulf, F., Lübbert, H. and Hoyer, D., Characterization of somatostatin receptor subtypes. In Somatostatin and Its Receptors, Ciba Foundation Symposium 190, Wiley, Chichester, UK, 1995, pp. 89-110.
12. Challis, R.A.J., Batty, I. and Nahorski, S.R., Mass measurements of inositol (1,4,5)-trisphosphate in rat cerebral cortex slices using a radioreceptor assay: effects of neurotransmitters and depolarization, Biochem. Biophys. Res. Commun., 157 (1988) 684-691.
13. Chesselet, M.F. and Reisine, T.D., Somatostatin regulates dopamine release in rat striatal slices and cat caudate nuclei, J. Neurosci., 3 (1983) 232-236.
14. Chneiweiss, H., Glowinski, J. and Premont, J., Vasoactive intestinal polypeptide receptors linked to an adenylate cyclase and their relationship with biogenic amine and somatostatin-sensitive adenylate cyclase on central neuronal and glial cells in primary cultures, J. Neurochem., 44 (1985) 779-786.
15. Chneiweiss, H., Glowinski, J. and Premont, J., Modulation by monoamines of somatostatin-sensitive adenylate cyclase on neuronal and glial cells from the mouse brain in primary cultures, J. Neurochem., 44 (1985) 1825-1831.
16. Chowdhury, M., Steardo, L. and Fillenz, M., Protein kinase C mediates the stimulation by somatostatin of dopamine synthesis in the rat striatum and nucleus accumbens, Neurosci. Lett., 82 (1987) 196-200.
17. Civelli, O., Bunzow, J.R. and Grandy, D.K., Molecular diversity of the dopamine receptors, Annu. Rev. Pharmacol. Toxicol., 32 (1993) 281-307.
18. Colas, B., Arilla, E. and Prieto, J.C., Somatostatin binding to a fresh rat astrocyte-enriched suspension, Neuropeptides, 23 (1992) 1-17.
19. Czernik, A.J. and Petrack, V., Somatostatin receptor binding in rat cerebral cortex. Characterization using a nonreducible somatostatin analog, J. Biol. Chem., 285 (1983) 5525-5530.
20. DiFiglia, M. and Aronin, N., Ultrastructural features of immunoreactive somatostatin neurons in the rat caudate nucleus, J. Neurosci., 2 (1982) 1267-1274.
21. Dorflinger, L.J. and Schonbrunn, A., Somatostatin inhibits basal and vasoactive intestinal peptide-stimulated hormone release by different mechanisms in GH pituitary cells, Endocrinology, 113 (1983) 1551-1558.
22. 2 receptor stimulation on somatostatin, neuropeptide Y, neurotensin, dynorphin and enkephalin, Brain Res., 581 (1992) 261-268.
23. Epelbaum, J., Somatostatin receptors in the central nervous system. In C. Weil, E.E. Müller and M.O. Thorner (Eds.), Basic and Clinical Aspects of Neuroscience, Springer, Berlin, Germany, 1992, pp. 17-28.
24. 2 dopamine receptors inhibits protein kinase C activity in striatal synaptosomes, J. Neurochem., 63 (1994) 169-176.
25. Gilman, A.G., A protein binding assay for adenosine 3′5′-cyclic monophosphate, Proc. Natl. Acad. Sci. USA, 67 (1970) 305-312.
26. 3H]DOPA in various regions of the brain, J. Neurochem., 13 (1966) 655-669.
27. Gonzales, R.A. and Crews, F.T., Guanine nucleotides stimulate production of inositol trisphosphate in rat cortical membranes, Biochem. J., 232 (1985) 799-804.
28. Houslay, M.D., Metcalfe, J.C., Warren, G.B., Hesketh, T.R. and Smith, G.A., The glucagon receptor of rat liver plasma membrane can couple to adenylate cyclase without activating it, Biochim. Biophys. Acta, 436 (1976) 489-494.
29. Hoyer, D., Bell, G.I., Berelowitz, M., Epelbaum, J., Feniuk, W., Humphrey, P.P.A., O'Carroll, A.-M., Patel, Y.C., Schonbrunn, A., Taylor, J.E. and Reisine, T., Classification and nomenclature of somatostatin receptors, Trends Pharmacol. Sci., 16 (1995) 86-88.
30. Johansson, O., Hokfelt, T. and Eide, R.P., Immunohistochemical distribution of somatostatin-like immunoreactivity in the central nervous system of the adult rat, Neuroscience, 13 (1984) 265-339.
31. Kelly, E., Batty, I. and Nahorski, S.R., Dopamine receptor stimulation does not affect phosphoinositide hydrolysis in slices of rat striatum, J. Neurochem., 51 (1988) 918-924.
32. Kluxen, F.-W., Bruns, C. and Lübbert, H., Expression cloning of a rat brain somatostatin receptor cDNA, Proc. Natl. Acad. Sci. USA, 89 (1992) 4618-4622.
33. Krantic, S., Martel, J.C., Weismann, D., Pujol, J.F. and Quirion, R., Quantitative autoradiographic study of somatostatin receptors heterogeneity in the rat extrahypothalamic brain, Neuroscience, 39 (1990) 127-137.
34. 1 receptor sub-type in frontal and temporal cortices in Alzheimer's disease, Brain Res., 573 (1992) 299-304.
35. Kubota, Y., Nagaki, S., Kito, S., Shimada, S., Okayama, T., Hatanaka, H., Pelletier, G., Takagi, H. and Tohyma, M., Neuropeptide Y-immunoreactive neurons receive synaptic inputs from dopaminergic axon terminals in the rat neostriatum, Brain Res., 458 (1988) 389-393.
36. Lachowicz, A., Pawlikowski, M. and Ochedalski, T., Somatostatin-14 increases the inositol-1,4,5-trisphosphate content in various areas of the brain, Biochem. Biophys. Res. Commun., 203 (1994) 379-384.
37. Law, S.F., Manning, D. and Reisine, T., Identification of the subunits of GTP-binding proteins coupled to somatostatin receptors, J. Biol. Chem., 266 (1991) 17885-17897.
38. Lee, N., Radke, J.M. and Vincent, S.R., Intracerebral cysteamine infusions attenuate the motor response to dopaminergic agonists, Behav. Brain Res., 29 (1988) 179-183.
39. Lowry, O.H., Rosenbrough, N.J., Farr, A.L. and Randall, R.J., Protein measurement with the folin phenol reagent, J. Biol. Chem., 193 (1951) 265-275.
40. 2-adrenoceptors, Mol. Brain Res., 25 (1994) 143-146.
41. 1-adrenergic activation of phospholipase C in striatal astrocytes through a mechanism involving arachidonic acid and glutamate, Proc. Natl. Acad. Sci. USA, 88 (1991) 9016-9020.
42. Markstein, R., Stockli, K.A. and Reubi, J.C., Differential effects of somatostatin on adenylate cyclase as functional correlate for different brain somatostatin receptor subpopulations, Neurosci. Lett., 104 (1989) 13-18.
43. Martin-Iverson, M.T., Radke, J.M. and Vincent, S.R., The effects of cysteamine on dopamine-mediated behaviours: evidence for dopamine-somatostatin interactions in the striatum, Pharmacol. Biochem. Behav., 24 (1986) 1707-1714.
44. Matozaki, T., Sakamoto, C., Nagao, M. and Baba, S., Protein kinase C regulates somatostatin binding to its receptors on rat pancreatic acinar cell membranes, Biomed. Res., 8 (1987) 39-44.
45. Munson, P.J. and Rodbard, D., A versatile computerized approach for characterization of ligand binding systems, Anal. Biochem., 107 (1980) 220-239.
46. Muñoz-Acedo, G., Izquierdo-Claros, R.M., Sánchez-Alonso, J.A., del Hoyo, N., Pérez-Albarsanz, M.A. and Arilla, E., Effect of somatostatin on the mass accumulation of inositol-1,4,5-trisphosphate in rat hypothalamus, striatum, frontoparietal cortex and hippocampus, Neurosci. Lett., 197 (1995) 41-44.
47. 2+ mobilization between bradykinin and agonists for pertussis toxin-sensitive G-protein-coupled receptors in NG 108-15 cells, FEBS Lett., 301 (1992) 223-226.
48. Onali, P., Olianas, M. and Gessa, G.L., Characterization of dopamine receptors mediating inhibition of adenylyl cyclase activity in rat striatum, Mol. Pharmacol., 28 (1985) 138-145.
49. Patel, Y.C. General aspects of the biology and function of somatostatin. In C. Weil, E.E. Müller and M.O. Thorner (Eds.), Basic and Clinical Aspects of Neuroscience, Vol. 4, Springer, Berlin, Germany, 1993, pp. 1-16.
50. Patel, Y.C., Greenwood, M.T., Warszynska, A., Panetta, R. and Srikant, C.B., All five cloned human somatostatin receptors (hS-STR1-5) are functionally coupled to adenylyl cyclase, Biochem. Biophys. Res. Commun., 198 (1995) 605-612.
51. Penney, J.B. and Young, A.B., Striatal in homogeneities and basal ganglia function, Movement Disord., 1 (1986) 3-15.
52. Pérez-Oso, E., Colás, B., López-Ruiz, M.P. and Arilla, E., Long-term haloperidol treatment decreases somatostatin binding in the rat brain, Neuropeptides, 13 (1989) 157-163.
53. 2 receptor stimulation inhibits inositol phosphate generating system in rat striatal slices, Brain Res., 456 (1988) 235-240.
54. Raynor, K., Lucki, I. and Reisine, T., Somatostatin receptors in the nucleus accumbens selectively mediate the stimulatory effect of somatostatin on locomotor activity in rats, J. Pharmacol. Exp. Ther., 265 (1993) 67-73.
55. Raynor, K. and Reisine, T., Differential coupling of somatostatin 1 receptors to adenylyl cyclase in the rat striatum vs. the pituitary and other regions of the rat brain, J. Pharmacol. Exp. Ther., 260 (1992) 841-848.
56. Reubi, J.C., New specific radioligand for one subpopulation of brain somatostatin receptors, Life Sci., 36 (1985) 1829-1836.
57. Rodríguez-Sánchez, M.N., López-Sañudo, S., Puebla, L., Rodríguez-Pena, M.S., Juarranz, M.G. and Arilla, E., Dopamine enhances somatostatin receptor-mediated inhibition of adenylate cyclase in rat striatum and hippocampus, J. Neurosci. Res., (in press).
58. Rubinstein, J.E. and Hitzemann, R.J., Further evidence against the coupling of dopamine receptors to phosphoinositide hydrolysis in rat striatum, Biochem. Pharmacol., 39 (1990) 1965-1970.
59. Salin, P., Mercugliano, M. and Chesselet, M.F., Differential effects of chronic treatment with haloperidol and clozapine on the level of preprosomatostatin mRNA in the striatum, nucleus accumbens, and frontal cortex, Cell. Mol. Neurobiol., 10 (1990) 127-143.
60. Scatchard, G., The attractions of proteins for small molecules and ions, Ann. NY Acad. Sci., 51 (1949) 660-671.
61. Schettini, G., Brain somatostatin: receptor-coupled transducing mechanisms and role in cognitive functions, Pharmacol. Res., 23 (1991) 203-215.
62. Schonbrunn, A. and Tashjian, A.H.J., Modulation of somatostatin receptors by thyrotropin-releasing hormone in a clonal pituitary cell strain, J. Biol. Chem., 255 (1980) 190-198.
63. Shogmonian, J.J. and Chesselet, M.F., Lesions of dopaminergic nigrostriatal pathway alter preprosomatostatin messenger RNA levels in the striatum, the entopeduncular nucleus and the lateral hypothalamus of the rata, Neuroscience, 42 (1991) 49-59.
64. Strange, P.G., Dopamine receptors: structure and function, Prog. Brain Res., 99 (1993) 167-179.
65. 2 receptors attenuate phosphatidylinositol 4,5-bisphosphate in synaptosomal membranes from rat neostriatum, J. Neurochem., 56 (1991) 136-140.
66. Vuillet, J., Kerkerian, L., Salin, P. and Nieoullon, A., Ultrastructural features of NPY-containing neurons in the rat striatum, Brain Res., 477 (1989) 241-251.
67. 2-dopamine receptor mediated inhibition of cyclic AMP formation in striatal neurons in primary culture, Mol. Pharmacol., 27 (1985) 595-599.